Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Roche is my take as our NMIBC jv partner

<< Previous

Bullboard Posts

Next >>

Comment by N0taP00pon Mar 07, 2023 3:16pm

143 Views

Post# 35324336

RE:Roche is my take as our NMIBC jv partner

Novartis could be another. They have their Keytruda equivalent blockbuster in Gleevec and their CEO has indicated they are looking out for early stage companies to buy or partner with. Opens all kinds of doors after BTD. At least, the dependence on retail investors will no longer be a crutch. Two months max to find out, I guess.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec